Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-Dose Glucagon for Prevention of Exercise-Induced Hypoglycemia in Type 1 Diabetes
NCT07427251Phase 4Recruiting
- Sponsor
- Steno Diabetes Center Copenhagen
- Start
- Apr 2026
- Primary completion
- May 2027
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of glucagon in type 1 diabetes mellitus (T1D), sponsored by Steno Diabetes Center Copenhagen. Started Apr 2026; status: recruiting.
02
Drugs
glucagon
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT07427251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07427251.